17-beta-hydroxysteroid dehydrogenase deficiency medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(14 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[masculinizing]] [[genitoplasty]]. Feminizing genitoplasty and [[gonadectomy]] must be performed, if female assignment is selected. <ref name="urlOrphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency">{{cite web |url=https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=752&lng=EN |title=Orphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency |format= |work= |accessdate=}}</ref>
{{CMG}}; {{AE}} {{Abdulkerim}}
==Overview==
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discussed, depending on the expected result of [[virilization]] [[genioplasty]].
 
==Medical therapy==
*If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender assignment]] should be discussed, depending on the expected result of [[virilization]] [[genioplasty]].
*Affected individuals who raised as male may [[virilize]] on their own or with the help of [[testosterone]] [[treatment]].
*In female patients who underwent [[gonadectomy]], appropriate intervention with [[estrogen]] therapy should be introduced at the time of puberty to induce [[secondary sexual characteristics]].
*Gender identity starts to develop around age 3 but it is not clear when it can be reliably assessed.
*The patient and family will require [[psychological]] [[counseling]] to accept the diagnosis and the [[infertility]] that follows it.<ref name="urlThe Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers">{{cite web |url=https://www.karger.com/Article/Fulltext/318004 |title=The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers |format= |work= |accessdate=}}</ref>
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs english review]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]

Latest revision as of 08:00, 20 October 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

17-beta-hydroxysteroid dehydrogenase deficiency medical therapy in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discussed, depending on the expected result of virilization genioplasty.

Medical therapy

References

  1. "The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency - FullText - Hormone Research in Paediatrics 2010, Vol. 74, No. 4 - Karger Publishers".

Template:WH Template:WS